Valuation: GENFIT

Market Cap 527M 603M 484M 451M 856M 57.38B 869M 5.81B 2.26B 28.21B 2.26B 2.21B 97.19B P/E 2025
-3.06x
P/E 2026 * 55.6x
Enterprise Value 472M 540M 434M 404M 767M 51.42B 779M 5.21B 2.02B 25.28B 2.03B 1.98B 87.1B EV / Sales 2025
2.34x
EV / Sales 2026 * 5.04x
Free-Float
86.88%
Yield 2025 *
-
Yield 2026 * -
1 day+22.31%
1 week+27.36%
Current month+22.08%
1 month+51.35%
3 months+73.69%
6 months+149.81%
Current year+145.77%
1 week 10.1
Extreme 10.1
12.98
1 month 8.15
Extreme 8.15
12.98
Current year 5.05
Extreme 5.05
12.98
1 year 3.05
Extreme 3.048
12.98
3 years 2.62
Extreme 2.62
12.98
5 years 2.62
Extreme 2.62
12.98
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 15/09/2019
Director of Finance/CFO 52 21/04/2021
Chief Tech/Sci/R&D Officer - 26/11/2025
Director TitleAgeSince
Chairman 70 15/06/2017
Director/Board Member 54 14/09/1999
Director/Board Member 58 15/06/2017
Date Insider Type Main position Quantity % Market Cap.
03-04Fiscal year

Chief Operating Officer

11,250 0.0225%
03-04Sell

Chief Operating Officer

7,083 0.0142%
03-04Fiscal year

Chief Operating Officer

10,625 0.0212%
Change 5-day change 1-year change 3-year change Capi.($)
+22.31%+27.36%+292.12%+260.45% 603M
+1.70%+7.41%+3.12%+8.46% 49.15B
+0.92%+6.21%+408.85%+607.44% 40.23B
+1.89%+11.06%+25.75%-7.89% 34.55B
+5.46%+8.10%+21.83%+66.94% 33.09B
+3.96%+6.07%+14.14%+37.68% 25.19B
+2.51%+4.94% - - 17.05B
+2.58%+7.24%+71.03%+132.17% 15.92B
+0.32%+0.58%+13.67%+19.09% 13.83B
-1.14%+7.52%+14.75%-30.83% 13.26B
Average +3.71%+6.44%+96.14%+121.50% 24.29B
Weighted average by Cap. +1.79%+6.32%+89.72%+132.24%

Financials

2025 2026 *
Net sales 66.82M 76.43M 61.4M 57.24M 109M 7.28B 110M 737M 287M 3.58B 287M 281M 12.33B 95.2M 109M 87.49M 81.55M 155M 10.37B 157M 1.05B 408M 5.1B 409M 400M 17.56B
Net income -8.3M -9.5M -7.63M -7.11M -13.49M -904M -13.69M -91.6M -35.61M -444M -35.65M -34.88M -1.53B 18.63M 21.31M 17.12M 15.96M 30.27M 2.03B 30.72M 206M 79.89M 997M 79.98M 78.27M 3.44B
Net Debt -54.72M -62.59M -50.29M -46.87M -88.91M -5.96B -90.25M -604M -235M -2.93B -235M -230M -10.1B -46.87M -53.61M -43.07M -40.15M -76.15M -5.1B -77.3M -517M -201M -2.51B -201M -197M -8.65B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
188
Date Price Change Volume
03/07/26 12.94 +22.31% 1,829,046
02/07/26 €10.58 +2.72% 146,371
01/07/26 €10.30 -2.83% 260,825
30/06/26 €10.60 +0.38% 259,509
29/06/26 €10.56 +3.94% 332,097
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
10.58EUR
Average target price
14.00EUR
Spread / Average Target
+32.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock